Robert Canter, M.D.

Robert J. Canter, M.D.



Surgery - Oncology





  • Professor


To see if Robert J. Canter is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

2279 45th Street
Sacramento, CA 95817
Driving Directions

Primary Phone:

4501 X St., Suite 3010
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 800-362-5566

Clinical Interests

Dr. Canter's clinical interests include soft tissue sarcoma, upper gastrointestinal (GI) malignancies including stomach, pancreas, and hepatobiliary. His research interests includes soft tissue sarcoma, radiologic and metabolic markers of response to neoadjuvant therapy, as well as novel treatment strategies for neoadjuvant therapy.

Dr. Canter's philosophy is to have coordinated care for the oncology patient.


Surgical Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


M.D., University of Pennsylvania School of Medicine, Philadelphia PA 1998

B.A., Princeton University, Princeton NJ 1992


General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1998-2005


Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2007

Board Certifications

American Board of Surgery, 2006

Professional Memberships

American College of Surgeons

American Society of Clinical Oncology

Association of Academic Surgeons

Connective Tissue Oncology Society

Pacific Coast Surgical Association

Society for Surgical Oncology

Honors and Awards

Christine and Helen Landgraf Award, UC Davis Comprehensive Cancer Center, 2014

Select Recent Publications

Wasif N, Tamurian RM, Christensen S, Do L, Martinez SR, Chen SL, Canter RJ. Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol. 2012 Feb;19(2):504-10. Epub 2011 Jul 16.

Tseng WH, Martinez SR, Do L, Tamurian RM, Borys D, Canter RJ. Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res. 2011 Jun 15;168(2):e173-80. Epub 2011 Mar 6.

Tseng WH, Martinez SR, Tamurian RM, Chen SL, Bold RJ, Canter RJ. Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol. 2011 Apr;103(5):390-4. doi: 10.1002/jso.21849. Epub 2010 Dec 28.

Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug;254(2):333-8.

Canter RJ, Beal S, Borys D, Martinez SR, Bold RJ, Robbins AS. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg. 2010 Feb;210(2):191-198.e2. Epub 2009 Dec 4.

Canter RJ, Martinez SR, Tamurian RM, Wilton M, Li CS, Ryu J, Mak W, Monsky WL, Borys D. Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol. 2010 Oct;17(10):2578-84. Epub 2010 Jun 17.

Canter, R.J., L-X. Qin, RG. Maki, M.F. Brennan, M. Ladanyi, S. Singer. A synovial sarcoma specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. Dee 15: 14(24) 8191-7. 2008

Canter, R.J., Qin r.x., Ferrone, C.R, Maki R.G., Singer, S, Brennan, M.F. Why do patients with low grade soft tissue sarcoma die? Ann Surg Oneal, Dee; 15(12):3550-60. 2008

Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG, Perioperative Chemotherapy in Patients Undergoing Pulmonary Resection for Metastatic Soft Tissue Sarcoma of the Extremity: A Retrospective Analysis. Cancer. 2007 Nov 1;110(9):2050-60.